6533b857fe1ef96bd12b3935
RESEARCH PRODUCT
Does Tocilizumab Indeed Reduce the Frequency of Th17 Cells? Comment on the Article by Thiolat et al
Paul OrnettiBernard BonnotteNona JanikashviliSylvain AudiaMaxime SamsonJean-francis Maillefertsubject
business.industryImmunologyArthritismedicine.diseasechemistry.chemical_compoundTocilizumabRheumatologychemistryAntigenImmunologyImmunology and AllergyMedicineExperimental pathologybusinessyear | journal | country | edition | language |
---|---|---|---|---|
2014-08-26 | Arthritis & Rheumatology |